Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Immunology
|
October 1, 1993
Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine
C Philippe, P Roux-Lombard, B Fouqueray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1995
Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity
V Boutard, R Havouis, B Fouqueray, et al.
European Cytokine Network
|
April 3, 2001
Transforming growth factor-beta inhibits interleukin-10 synthesis by human monocytic cells
S Suberville, A Bellocq, I Peguillet, et al.
European Journal of Immunology
|
November 1, 1996
Regulation of interleukin-10 production by beta-adrenergic agonists
S Suberville, A Bellocq, B Fouqueray, et al.
Clinical and Experimental Immunology
|
October 1, 1993
Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients
J Cadranel, C Philippe, B Philippe, et al.
Kidney International
|
May 1, 1991
Desferrioxamine regulates tumor necrosis factor release in mesangial cells
H Affres, J Perez, J Hagege, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
June 1, 1988
[Comparison of 3 methods of blood pressure measurement in obesity]
J Julien, J Y Pagny, X Jeunemaitre, et al.
Kidney International
|
April 1, 1996
Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells
P Grellier, M Sabbah, B Fouqueray, et al.
Acta Anaesthesiologica Scandinavica
|
April 20, 2001
Haemodynamic changes and vasopressin release are not consistently associated with carbon dioxide pneumoperitoneum in humans
C Lentschener, O Axler, H Fernandez, et al.
The Journal of Clinical Investigation
|
March 1, 1995
Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy
U O Wenzel, B Fouqueray, P Biswas, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Immunology
|
October 1, 1993
Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine
C Philippe, P Roux-Lombard, B Fouqueray, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 15, 1995
Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity
V Boutard, R Havouis, B Fouqueray, et al.
European Cytokine Network
|
April 3, 2001
Transforming growth factor-beta inhibits interleukin-10 synthesis by human monocytic cells
S Suberville, A Bellocq, I Peguillet, et al.
European Journal of Immunology
|
November 1, 1996
Regulation of interleukin-10 production by beta-adrenergic agonists
S Suberville, A Bellocq, B Fouqueray, et al.
Clinical and Experimental Immunology
|
October 1, 1993
Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients
J Cadranel, C Philippe, B Philippe, et al.
Kidney International
|
May 1, 1991
Desferrioxamine regulates tumor necrosis factor release in mesangial cells
H Affres, J Perez, J Hagege, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
June 1, 1988
[Comparison of 3 methods of blood pressure measurement in obesity]
J Julien, J Y Pagny, X Jeunemaitre, et al.
Kidney International
|
April 1, 1996
Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells
P Grellier, M Sabbah, B Fouqueray, et al.
Acta Anaesthesiologica Scandinavica
|
April 20, 2001
Haemodynamic changes and vasopressin release are not consistently associated with carbon dioxide pneumoperitoneum in humans
C Lentschener, O Axler, H Fernandez, et al.
The Journal of Clinical Investigation
|
March 1, 1995
Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy
U O Wenzel, B Fouqueray, P Biswas, et al.
Page
of 5